Healthcare and Life Science
AI, Credit, and Our Human Future: A Question of Capability, Not Just Technology
Visibility and value: As AI-generated outputs become more prominent, many of the human contributions that enable them remain behind the scenes. Artificial intelligence is advancing at remarkable speed. ...
TTP releases new e-book on closing the loop in neuromodulation therapy
TTP has released a new e-book exploring how closed-loop neuromodulation systems can deliver more personalised, responsive therapies. It examines the role of clinically meaningful biomarkers, algorithms, and system-level design in turning real-time sensing into reliable treatment. The e-...
Addenbrooke’s unveils transformed urgent and emergency care spaces and digital innovations for winter
Transformed urgent and emergency care areas and a new digital registration and triage tool are part of plans by teams at Cambridge University Hospitals to help patients get the right treatment in the right place as quickly as possible this winter. ...
Cambridge Dining Co. - crafting exceptional events
CAMBRIDGE DINING CO. — CRAFTING EXCEPTIONAL EVENTS At Cambridge Dining Co., we are trusted by clients across the region to deliver superior event management, wedding planning and award-winning catering services. Our mission is simple, to create personalised experiences that reflect...
New IDTechEx Report: Sensor Market 2026-2036
IDTechEx forecasts that the global sensor market will reach US$250B by 2036 as global mega-trends in mobility, AI, robotics, 6G connectivity and IoT drive sensor demand. IDTechEx's newly updated "Sensor Market 2026-2036: Technologies, Trends, Players, Forecasts" report provides extensiv...
Why startups are choosing Peterborough
For years, Cambridge has dominated conversations about innovation in the East of England. But whilst Cambridge continues to thrive, something interesting is happening just down the A1: Peterborough is quietly emerging as a compelling option for startups and scale-ups. ...
Cambridge NeuroWorks drives UK neurotech forward with launch of nationwide Blue Sky Proof-of-Concept Fund
Cambridge NeuroWorks announces a new UK-wide initiative designed to power high-risk, high-impact experimentation in early-stage neurotechnology. ...
Beta Launch of LYEONS Heart
The Beta Launch of 23 LYEONS Heart devices is now live!
VALANX Biotech establishes Board of Directors
Renowned industry leaders, Michael Boehler, Alexander Schwartz, Urs Spitz and Ingo Nagler, appointed to guide strategic and commercial development ...
Enterprise Therapeutics publishes results of Phase 1 study of ETD001, a novel inhaled ENaC blocker for treatment of Cystic Fibrosis, in The Journal of Cystic Fibrosis
ETD001 is well tolerated in healthy individuals at higher doses than predicted to be therapeutic for long-lasting enhancement of mucociliary clearanceResults showed excellent consistency between preclinical and clinical behaviour of ETD001Phase 2 trial of ETD001 in people with cystic fi...